Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | UTHR | SMMT | ||
| Company | Neurocrine Bioscienc | United Therapeutic | Summit Therapeu ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 130.22 | 460.98 | 16.65 | ||
| High | 134.77 | 470.98 | 16.78 | ||
| Low | 129.17 | 455.63 | 16.03 | ||
| Latest | 134.54 | 468.07 | 16.06 | ||
| Change | +2.15 | +3.14 | -0.98 | ||
| % Change | +1.62% | +0.68% | -5.75% | ||
| Volume | 1,056,021 | 420,354 | 3,207,030 | ||
| 20-Day Average Volume | 1,096,706 | 420,938 | 2,722,727 | ||
| Previous Close | 132.39 | 464.93 | 17.04 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 139.24 | 492.82 | 17.82 | ||
| 20-Day Raw Stochastic | 27.69% | 19.33% | 0.72% | ||
| 20-Day Relative Strength | 41.44 | 43.39 | 40.97 | ||
| Weighted Alpha | -4.47 | +25.29 | -27.97 | ||
| Today's Opinion | 8% Sell | 56% Buy | 88% Sell | ||
| Previous Opinion | 8% Sell | 56% Buy | 80% Sell | ||
| Last Month's Opinion | 64% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.42% since 01/12/26 | -2.97% since 01/12/26 | -5.75% since 01/12/26 | ||
| Low | 129.17 on 01/20/26 | 455.63 on 01/20/26 | 16.03 on 01/20/26 | ||
| High | 135.98 on 01/15/26 | 484.22 on 01/13/26 | 17.86 on 01/15/26 | ||
| 1-Month | |||||
| %Chg | -7.21% since 12/19/25 | -9.49% since 12/19/25 | -9.88% since 12/19/25 | ||
| Low | 129.17 on 01/20/26 | 455.63 on 01/20/26 | 16.03 on 01/20/26 | ||
| High | 148.56 on 12/23/25 | 519.99 on 12/23/25 | 20.20 on 01/09/26 | ||
| 3-Month | |||||
| %Chg | -4.80% since 10/20/25 | +8.18% since 10/20/25 | -19.84% since 10/20/25 | ||
| Low | 129.17 on 01/20/26 | 409.07 on 10/28/25 | 15.62 on 11/21/25 | ||
| High | 160.18 on 12/08/25 | 519.99 on 12/23/25 | 20.51 on 10/22/25 | ||
| 6-Month | |||||
| %Chg | +1.91% since 07/18/25 | +60.29% since 07/18/25 | -38.70% since 07/18/25 | ||
| Low | 123.67 on 08/08/25 | 272.12 on 07/31/25 | 15.62 on 11/21/25 | ||
| High | 160.18 on 12/08/25 | 519.99 on 12/23/25 | 30.98 on 08/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,200,078 | 20,018,486 | 13,140,398 | ||
| Shares Outstanding, K | 99,706 | 43,057 | 771,150 | ||
| Annual Sales | 2,355,300,000 | 2,877,400,000 | 0 | ||
| Annual Net Income | 341,300,000 | 1,195,100,000 | -221,320,000 | ||
| Last Quarter Sales | 794,900,000 | 799,500,000 | 0 | ||
| Last Quarter Net Income | 209,500,000 | 338,700,000 | -231,790,000 | ||
| 60-Month Beta | 0.28 | 0.84 | -1.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.04 on 10/28/25 | 7.16 on 10/29/25 | -0.31 on 10/20/25 | ||
| Latest Earnings Date | 02/05/26 | 02/25/26 | 02/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 31.90 | 17.89 | 0.00 | ||